ATE180167T1 - Inhibition der ausscheidung von natrium durch die na-k-atpase - Google Patents

Inhibition der ausscheidung von natrium durch die na-k-atpase

Info

Publication number
ATE180167T1
ATE180167T1 AT91918625T AT91918625T ATE180167T1 AT E180167 T1 ATE180167 T1 AT E180167T1 AT 91918625 T AT91918625 T AT 91918625T AT 91918625 T AT91918625 T AT 91918625T AT E180167 T1 ATE180167 T1 AT E180167T1
Authority
AT
Austria
Prior art keywords
compounds
atpase
inhibition
natriuretic
sodium excretion
Prior art date
Application number
AT91918625T
Other languages
English (en)
Inventor
Harvey C Gonick
Elmar Weiler
Farhad Khalil-Manesh
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE180167T1 publication Critical patent/ATE180167T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K4/00—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C07K4/12—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT91918625T 1990-09-11 1991-09-11 Inhibition der ausscheidung von natrium durch die na-k-atpase ATE180167T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58158290A 1990-09-11 1990-09-11

Publications (1)

Publication Number Publication Date
ATE180167T1 true ATE180167T1 (de) 1999-06-15

Family

ID=24325750

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91918625T ATE180167T1 (de) 1990-09-11 1991-09-11 Inhibition der ausscheidung von natrium durch die na-k-atpase

Country Status (9)

Country Link
US (1) US5667811A (de)
EP (1) EP0500921B1 (de)
AT (1) ATE180167T1 (de)
AU (1) AU650490B2 (de)
CA (1) CA2068412A1 (de)
DE (1) DE69131248T2 (de)
DK (1) DK0500921T3 (de)
OA (1) OA09700A (de)
WO (1) WO1992004910A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000044931A2 (en) * 1999-01-28 2000-08-03 Bion, Inc. High-throughput screening assays for modulators of atpase

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4321120A (en) * 1980-03-19 1982-03-23 Nardi Ronald V Process for detecting proteins specific to hypertension in mammals
US4665019A (en) * 1983-08-31 1987-05-12 University Of Maryland Method for measuring the plasma levels of an inhibitor of (Na+ +K.sup.+
JPS6060557A (ja) * 1983-09-13 1985-04-08 Eisai Co Ltd Ｐｉｖｋａ−２の測定方法および試薬
US4943533A (en) * 1984-03-01 1990-07-24 The Regents Of The University Of California Hybrid cell lines that produce monoclonal antibodies to epidermal growth factor receptor
DE3445933A1 (de) * 1984-12-17 1986-06-19 Röhm GmbH, 6100 Darmstadt Arzneimittel mit diuretischer wirksamkeit
GB8516081D0 (en) * 1985-06-25 1985-07-31 Ciba Geigy Ag Assay & purification of amyloid components
US4780314A (en) * 1985-10-30 1988-10-25 Brigham And Women's Hospital Isolation and purification of a digitalis-like factor
US4940670A (en) * 1986-01-24 1990-07-10 Rhodes Buck A Method for compounding and testing patient specific monoclonal antibodies and monoclonal antibody fragments for in vivo use
FR2597483B1 (fr) * 1986-04-18 1993-09-10 Flork Michel Nouveaux peptides diuretiques et natriuretiques.
US4746652A (en) * 1986-11-18 1988-05-24 Wake Forest University Method of inducing diuresis with lysophospholipids
US4940782A (en) * 1987-06-08 1990-07-10 G. D. Searle & Co. Monoclonal antibodies against IgE-associated determinants, hybrid cell lines producing these antibodies, and use therefore

Also Published As

Publication number Publication date
CA2068412A1 (en) 1992-03-12
US5667811A (en) 1997-09-16
OA09700A (en) 1993-08-30
WO1992004910A1 (en) 1992-04-02
EP0500921A1 (de) 1992-09-02
DE69131248D1 (de) 1999-06-24
EP0500921B1 (de) 1999-05-19
AU650490B2 (en) 1994-06-23
DE69131248T2 (de) 1999-12-16
DK0500921T3 (da) 1999-11-29
EP0500921A4 (en) 1993-05-26
AU8761791A (en) 1992-04-15

Similar Documents

Publication Publication Date Title
FI822279A7 (fi) Tulehdus- ja immuunisairauksiin ja sileiden lihasten spasmien yhteydessä esiintyviin sairauksiin käytettäkäytettävät farmaseuttiset koostumukset.
ES2192839T3 (es) Timosina beta 4 oxidada.
EA200001223A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
EA200001224A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
ATE31243T1 (de) Verwendung von 4-aminosalicylsaeure als entzuendungshemmender wirkstoff.
ES2102196T3 (es) Periferializacion de celulas pluripotenciales hematopoyeticas.
NO1994018I1 (no) Mometasonfuroat
KR950700333A (ko) 개량된 알파 인터페론 조성물 및 인간 말초혈 백혈구로부터의 제조 방법(improved alpha interferon composition and method for its production from human peripheral blood leukocytes)
IS4073A (is) Nýtt fjölvirknislyf gegn aukningu mótstöðu
UA6035A1 (uk) Засіб для визначення лейкоцітів в сечі
ATE162075T1 (de) Pharmazeutisches kombinationspräparat, das ein uricosurisches mittel und einen excitatorischen aminosäure-antagonisten enthält
DE69723863D1 (de) Chinoline und deren therapeutische verwendung
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
GR3018304T3 (en) Antiatherosclerotic and antithrombotic 2-amino-6-phenyl-4h-pyran-4-ones.
BG93298A (bg) Имуностимулиращи 6-арил-5,6-дихидроимидазо(2,1-в)тиазолови производни
DK0471718T3 (da) Paracetamolholdigt farmaceutisk præparat
ATE180167T1 (de) Inhibition der ausscheidung von natrium durch die na-k-atpase
NL7804192A (nl) Cyclohexaancarbonzuur en de derivaten hiervan, evenals de toepassing van deze stoffen als therapeutisch mid- del.
IT1136568B (it) Composizioni per l'idratazione delle sostanze cheratiniche,costutuite da solfossidi di alfa-ammino-acidi
FR2362852A1 (fr) Derives de la phenothiazine, leur preparation et leurs utilisations therapeutiques
NO902157L (no) Butensyrederivater for terapeutisk anvendelse.
ES2128313T3 (es) Naftalimidas n-substituidas, su obtencion y empleo.
IT8223309A0 (it) Composizione farmaceutica per il trattamento di malattie cardiovascolari.
DE3873278D1 (de) Aryl-substituierte thiophen-3-ole, ihre derivate und analoge als lipoxygenase-inhibitoren.
EA199700451A1 (ru) Мономерные 4,4-(дизамещенные) циклогексан-1-олы и родственные соединения

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee